NU-ALLOPURINOL 200 MG
ALLOPURINOL : 200 MG · DIN 02335859 · NU-PHARM INC
Health Canada status: CANCELLED (UNRETURNED ANNUAL)
What is NU-ALLOPURINOL?
NU-ALLOPURINOL 200 MG contains ALLOPURINOL : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 02335859, held by NU-PHARM INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled (unreturned annual), status dated 28-Mar-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02335859 |
|---|---|
| Brand name | NU-ALLOPURINOL |
| Generic / active ingredient | ALLOPURINOL : 200 MG |
| Manufacturer | NU-PHARM INC |
| Strength | 200 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | M04AA01 ALLOPURINOL |
| AHFS class | 92:16.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED (UNRETURNED ANNUAL) |
| Status date | 28-Mar-2018 |
What can be used instead?
Other Canadian products sharing ATC code M04AA01 ALLOPURINOL. 12 of 51 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALLOPURINOL-100 | 100 MG | TABLET | PRO DOC LIMITEE | MARKETED | DIN 00555681 |
| ALLOPURINOL-200 | 200 MG | TABLET | PRO DOC LIMITEE | MARKETED | DIN 02130157 |
| ALLOPURINOL-300 | 300 MG | TABLET | PRO DOC LIMITEE | MARKETED | DIN 00555703 |
| APO-ALLOPURINOL TABLETS | 100 MG | TABLET | APOTEX INC | MARKETED | DIN 00402818 |
| APO-ALLOPURINOL TABLETS | 200 MG | TABLET | APOTEX INC | MARKETED | DIN 00479799 |
| APO-ALLOPURINOL TABLETS | 300 MG | TABLET | APOTEX INC | MARKETED | DIN 00402796 |
| JAMP ALLOPURINOL | 100 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02421593 |
| JAMP ALLOPURINOL | 200 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02421607 |
| JAMP ALLOPURINOL | 300 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02421615 |
| MAR-ALLOPURINOL | 100 MG | TABLET | MARCAN PHARMACEUTICALS INC | MARKETED | DIN 02396327 |
Who else supplies ALLOPURINOL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ALLOPURINOL appears in 369 registered pack listings across 14 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled (unreturned annual) in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.